Skip to content
PEPTIDESUNCENSORED

About

An atlas that shows its work.

Peptides Uncensored is an education project. It exists because the gap between what gets repeated online and what trials actually show is enormous, and most of the internet sits on the repeated side of it.

Evidence-gradedEvery figure labeledReviewed 2026-09-26
Peptides Uncensored logo: a magnifying glass over a peptide molecule

Why it exists

Forum claims on one side, trial data on the other

Search for almost any peptide and you land on one of two things: a product page written like a sales brochure, or a forum thread where a dose from years ago has been copied so often it feels like a fact.

The published record is usually smaller, stranger and more interesting than either. Sometimes it is a stack of rodent studies from one lab. Sometimes it is a 72-week randomized trial with thousands of people. Those deserve very different levels of confidence, and most of the internet presents them the same way.

This atlas puts the claims and the data side by side and labels which is which.

Forum claims

  • A dose repeated until it feels like a fact
  • Rat mechanisms presented as human results
  • Purity claims nobody can check
  • Stacks nobody has tested together

Trial data

  • Randomized, controlled, measured
  • Side effects counted, not vibes
  • Often smaller effects than the forums promise
  • Sometimes it simply does not exist yet

The atlas sits in between and labels which is which.

Editorial policy

Six commitments, stated so you can hold us to them

  • Grades follow the evidence

    A grade moves only when the published record moves. Popularity, hype and demand do not change it.

  • Unknowns stated up front

    Thin human data is said on the first screen of every dossier, not buried in a footer.

  • Corrections in the open

    Errors are fixed and significant changes are noted on the page. Send a correction.

  • Every figure labeled by source

    FDA label, clinical trial range or commonly reported range. How labels work.

  • Grades defined publicly

    The A to D rubric is published word for word, with the method and its limits. Read the rubric.

  • Reviewed on a stated cadence

    The atlas is reviewed at least every three months, and sooner when a trial reads out, a label changes, FDA acts or the WADA list updates. Last full review: 2026-09-26.

It will never

  • Tell anyone what to take
  • Publish injection or preparation instructions
  • Present animal data as human results

How it is built

From primary source to dossier

  1. 01

    Primary sources first

    FDA labels (via DailyMed), PubMed, ClinicalTrials.gov, and FDA and WADA documents. Secondary sources are used for context, and only when they check out.

  2. 02

    Known, claimed, unknown

    Each dossier leads with what is established, then what is claimed, then what nobody knows. Thin human data is stated on the first screen, not in a footer.

  3. 03

    Every number labeled

    Doses carry their source. A number that cannot be pinned down is marked poorly characterized or left out, never guessed.

  4. 04

    Graded in public

    Each compound gets one grade against the published rubric. When it sits between two grades, it gets the lower one.

  5. 05

    Citations you can check

    Sources link to live PubMed, DailyMed or trial-registry searches, so you can verify them yourself. Nothing is cited that we have not described accurately.

  6. 06

    Dated and re-reviewed

    Every page carries a last-reviewed date. Grades and figures are re-checked on each review cycle.

Contact

Corrections and feedback

What is this about?

Opens your email app with the message filled in.

Or email directly

dave@peptidesuncensored.com

A useful report includes

  • The page and the exact claim
  • Why you think it is wrong
  • A source: PubMed ID, FDA label or trial registry number

Factual errors are corrected, and significant changes are noted on the page. Personal medical questions cannot be answered.